For more information, visit LGS-CORE Study. The Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS. It educates the ...

Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Lennox Gastaut Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Lennox Gastaut Syndrome – Market Insights, Epidemiology, and ...

Please provide your email address to receive an email when new articles are posted on . “Most patients with [Lennox-Gastaut syndrome (LGS)] develop between three and five seizure types that wax and ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending fenfluramine (Fintepla) for treating seizures associated with Lennox-Gastaut syndrome. The ...

Epidiolex, a pharmaceutical formulation of cannabidiol (CBD), continued to show benefits for people with Lennox-Gastaut syndrome and Dravet syndrome, real-world data showed. Seizure frequency was ...

A Takeda Pharmaceutical drug in development for rare forms of epilepsy that are resistant to anti-seizure medications has failed to meet the main goals of two placebo-controlled pivotal studies, a ...

Please provide your email address to receive an email when new articles are posted on . Clinical outcome assessments currently used for people with Lennox-Gastaut syndrome and Dravet syndrome were ...

SANTA BARBARA COUNTY, Calif. – The Lennox-Gastaut Syndrome (LGS) Foundation held its 7th annual Walk 'n' Wheel in Santa Barbara to raise awareness of the condition and increase funding for research.

LONDON--(BUSINESS WIRE)--The global Lennox-Gastaut syndrome (LGS) treatment market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report ...